Accenture Is Down 37% From Its Peak. Does the AI Transformation Story Still Hold Up?
Accenture ( ACN ) spent most of the past decade as one of the more dependable large-cap compounders in technology services. The business is essentially what happens when a company gets very large at helping other companies change: consulting, outsourcing, technology implementation, and now AI integration , spread across clients in virtually every industry on the planet.
Governments, banks, healthcare systems, and consumer goods companies: the engagements tend to be long, complex, and hard to walk away from.
The stock peaked above $291 earlier this year and has since dropped more than 37%, sitting around $181 at last close. Things got considerably uglier in late June , when the drawdown hit nearly 57% from the high, one of the steeper declines among large-cap names this year.
A few things drove the damage. Federal government contract cancellations hit the public sector business hard earlier in the year, and cautious enterprise IT budgets weighed on new bookings more broadly.
Q3 FY2026 revenue of $16.7 billion grew 4% in local currency , which is a fine number in isolation but a jarring contrast to the growth rates the stock used to price in. New bookings of $9.8 billion for the quarter came in softer than many had hoped.
Slower revenue growth is worth watching. A business that stops generating cash is worth worrying about, and Accenture is not in that category. Free cash flow reached nearly $10.9 billion in fiscal year 2025, the strongest figure in at least four years and a meaningful step up from the $8.6 billion the company generated the prior year.
Guidance for fiscal 2026 puts free cash flow in the $9.8 to $10.8 billion range, keeping it at roughly that same level. A company pulling in that kind of cash at an $111 billion market cap is not in distress, whatever the chart looks like.
Accenture has kept returning capital through the downturn too, with a dividend yielding close to 4% at current prices and a buyback program that management has continued funding.
On the AI front, the narrative has more grounding than the typical consulting pitch. Accenture booked $3 billion in AI-related new sales in Q3 FY2026 alone.
CEO Julie Sweet has made the point repeatedly that AI does not reduce demand for what Accenture does. Clients need more implementation help when they are trying to adopt complex new technology, not less, and Accenture has been building those capabilities through both internal investment and acquisitions.
The TIKR valuation model mid case lands at a price target of around $272, implying roughly 11% annualized returns from current levels over the next several years.
The revenue growth assumption of around 5% annually is actually below what Accenture has historically delivered, which gives the model some cushion rather than requiring an optimistic outcome to make the math work.
One thing worth saying clearly: the Street's mean target of around $187 barely clears the current price of $181. Analysts are not exactly pounding the table here, and that skepticism reflects real uncertainty about when growth picks back up.
The P/E compression baked into the mid case, around 5% annually, acknowledges that the premium multiple ACN carried for years is unlikely to fully return.
Extending the model to 2034, the mid-case forecasted return reaches around 98% at roughly a 9% IRR, solid, but not the kind of number that makes this an obvious high-conviction bet.
The bull case starts with a business generating close to $11 billion in free cash flow annually, paying a nearly 4% dividend, and sitting at the intersection of AI adoption and enterprise transformation at global scale.
At around 13 times forward earnings, the valuation is the cheapest it has been in years , and the drawdown has arguably more than priced in the headwinds around government contracts and spending caution.
The bear case is harder to brush off than it normally would be for a company this size. The Street target barely implies any upside, growth has been genuinely sluggish, and federal contract exposure is not going away quickly.
The AI services ramp is real, but it is gradual, and a 5% revenue growth assumption still requires better execution than the last few quarters have shown. Accenture is a high-quality business in a difficult stretch, and the honest question is whether $181 is enough of a discount to make the wait worthwhile.
